| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Spero Therapeutics, Inc. | Director | Common Stock | 75,000 | $54,750 | $0.7300 | 12 Jun 2025 | Direct |
| PARDES BIOSCIENCES, INC. | Director | Stock Option (Right to Buy) | 0 | 31 Aug 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| SPRO | Spero Therapeutics, Inc. | 12 Jun 2025 | 1 | $0 | 4 | Director | 16 Jun 2025, 20:26 |
| SPRO | Spero Therapeutics, Inc. | 29 May 2024 | 1 | $0 | 4 | Director | 30 May 2024, 16:15 |
| SPRO | Spero Therapeutics, Inc. | 05 Oct 2023 | 1 | $0 | 4 | Director | 10 Oct 2023, 17:43 |
| /report/000120919123047829-pottage-john-c-jr-2023-08-31 | PARDES BIOSCIENCES, INC. | 31 Aug 2023 | 2 | $0 | 4 | Director | 31 Aug 2023, 15:49 |
| /report/000120919123033679-pottage-john-c-jr-2023-06-01 | PARDES BIOSCIENCES, INC. | 01 Jun 2023 | 1 | $0 | 4 | Director | 02 Jun 2023, 16:12 |
| SPRO | Spero Therapeutics, Inc. | 15 Sep 2022 | 1 | $0 | 4 | Director | 19 Sep 2022, 17:44 |
| /report/000120919122050300-pottage-john-c-jr-2022-09-14 | PARDES BIOSCIENCES, INC. | 14 Sep 2022 | 1 | $0 | 4 | Director | 16 Sep 2022, 16:08 |
| /report/000120919122050282-pottage-john-c-jr-2022-09-14 | PARDES BIOSCIENCES, INC. | 14 Sep 2022 | 0 | $0 | 3 | Director | 16 Sep 2022, 16:04 |
| SPRO | Spero Therapeutics, Inc. | 17 Aug 2021 | 1 | $0 | 4 | Director | 18 Aug 2021, 17:07 |